STAND. COM. REP. NO.  1590

 

Honolulu, Hawaii

                , 2021

 

RE:   H.C.R. No. 110

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirty-First State Legislature

Regular Session of 2021

State of Hawaii

 

Sir:

 

     Your Committee on Consumer Protection & Commerce, to which was referred H.C.R. No. 110, H.D. 1, entitled:

 

"HOUSE CONCURRENT RESOLUTION REQUESTING THE AUDITOR TO UPDATE ITS REPORT NO. 12-09, WHICH ASSESSES THE SOCIAL AND FINANCIAL EFFECTS OF MANDATORY HEALTH INSURANCE COVERAGE FOR FERTILITY PRESERVATION PROCEDURES FOR PERSONS OF REPRODUCTIVE AGE WHO HAVE BEEN DIAGNOSED WITH CANCER AND WILL UNDERGO TREATMENT THAT, BASED ON A MEDICAL DETERMINATION BY THE PERSON'S PHYSICIAN, WILL MOST LIKELY CAUSE INFERTILITY,"

 

begs leave to report as follows:

 

     The purpose of this measure is to request that the Auditor update its Report No. 12-09, which assesses the social and financial effects of mandatory health insurance coverage for fertility preservation procedures for persons of reproductive age who have been diagnosed with cancer and who will undergo treatment likely to cause infertility.

 

     Your Committee received testimony in support of this measure from the Hawaii Society of Clinical Oncology and Association for Clinical Oncology.  Your Committee received comments on this measure from the Office of the Auditor and Hawaii Medical Service Association.

 

     Your Committee finds that certain cancers and cancer treatment procedures may affect a person's fertility by damaging the person's reproductive organs.  Although fertility may be preserved through preservation procedures, the high cost of these procedures and the narrow window to obtain services means these procedures are unattainable for many people.  Your Committee further finds that in 2012, the Legislature requested the Auditor to conduct a study to assess the social and financial impacts of mandating insurance coverage for fertility preservation procedures for persons of reproductive age who have been diagnosed with cancer and will be undergoing treatment that might adversely affect their fertility.  However, because of insufficient data at the time, the Auditor was unable to assess the social and financial impacts of the proposed mandated coverage.

 

     Your Committee notes that since 2012, ten states have enacted fertility preservation coverage, and the experience in those ten other states will allow the Auditor to evaluate additional experiential data and assess actual financial impacts.  Your Committee therefore believes that an update to Report No. 12-09 is necessary to properly assess the cost and viability of offering mandatory fertility preservation coverage, as such coverage may increase overall health care insurance costs for the entire pool of insured persons and could be considered a new mandate that would involve cost defrayment by the State.

 

     As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee concurs with the intent and purpose of H.C.R. No. 110, H.D. 1, and recommends its adoption.

 

 

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

 

 

 

 

____________________________

AARON LING JOHANSON, Chair